Uluslararası / International
Brezilya / Brasil
Kanada / Canada
Latin Amerika / Latinoamérica
Amerika Birleşik Devletleri / USA
Avusturya / Österreich
Bosna Hersek / Босна и Херцеговина
Bulgaristan / България
Hırvatistan / Hrvatska
Çek Cumhuriyeti & Slovakya / Česká republika & Slovensko
Fransa / France
Almanya / Deutschland
Yunanistan / ΕΛΛΑΔΑ
Macaristan / Hungary
İtalya / Italia
Hollanda / Nederland
İskandinav / Nordic
Polonya / Polska
Portekiz / Portugal
Romanya & Moldova / România & Moldova
Slovenya / Slovenija
Sırbistan & Karadağ / Србија и Црна Гора
ispanya / España
İsviçre / Schweiz
İngiltere ve İrlanda / UK & Ireland
Çin / 中国
Hindistan / भारत गणराज्य
Japonya / 日本
Pakistan / Pākistān
Vietnam / Việt Nam
ASEAN / ASEAN
İsrail / מְדִינַת יִשְׂרָאֵל
Cezayir, Fas ve Tunus / الجزائر والمغرب وتونس
Orta Doğu / Middle East
:sharpen(level=0):output(format=webp)/up/dt/2025/07/1920-1080.jpg "Suriye’de Dental Sektör için Önemli Fırsatlar")
:sharpen(level=0):output(format=webp)/up/dt/2025/07/Ingiltere-Dental-Kariyer-Yolculugu-Bilgi-Hatti-Foto-1920-1080.jpg "İngiltere Dental Kariyer Yolculuğu Bilgi Hattı Kuruldu")
:sharpen(level=0):output(format=webp)/up/dt/2025/07/MOU-imza-toreni-20250707_164644-1920-1080-Kopya.jpg "Özbekistan’dan IDEV ile Knightsbridge Academy Arasında Uluslararası Eğitim İş Birliği Protokolü")
:sharpen(level=0):output(format=webp)/up/dt/2025/05/Myobrace-System.jpg "Myobrace, Myoretainr ve Myosa: yenilikçi miyofonksiyonel tedavi sistemleri")
:sharpen(level=0):output(format=webp)/up/dt/2025/05/DSC_0146-1920-1080.jpg "Diş Sağlığını Koruyacak Proje Başladı: ‘Arayı Açmayalım’")
:sharpen(level=0):output(format=webp)/up/dt/2025/07/3dprinting.jpg "3D printing")
:sharpen(level=0):output(format=webp)/up/dt/2025/07/aligners.jpg "aligners")
:sharpen(level=0):output(format=webp)/up/dt/2014/02/FKG.png "FKG Dentaire")
:sharpen(level=0):output(format=webp)/up/dt/2022/05/osstem_logo.png "Osstem Implant"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2023/03/ACTEON_NEW-logo_03-2024.png "ACTEON"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2014/02/EMS.png "EMS")
:sharpen(level=0):output(format=webp)/up/dt/2024/05/Curaden_Logo_RGB1.png "Curaden"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/2011/11/ITI-LOGO.png "ITI International Team for Implantology"){kind=logo}
:sharpen(level=0):output(format=webp)/up/dt/e-papers/354655/1.jpg "DT Turkey No. 1, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/350231/1.jpg "DT Turkey No. 4, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/347784/1.jpg "DT Turkey No. 3, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/342388/1.jpg "DT Turkey No. 2, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/338358/1.jpg "DT Turkey No. 1, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/334259/1.jpg "DT Turkey No. 4, 2023")
E-papers
E-dergi sürümleri, DTI basılı yayınlarının tam dijital kopyalarıdır. Okuyucular, e-dergi içinde arama yapabilir ve gezinebilir, ayrıca çevrimdışı okumak için sayfaları indirebilir ve yazdırabilir. Uluslararası okuyucularımıza geniş yayılımı teşvik etmek için çoğu e-dergiye erişim ücretsizdir.
:sharpen(level=0):output(format=webp)/up/dt/e-papers/322861/1.jpg "DT Middle East & Africa Edition No. 3, 2023")
DT Middle East & Africa Edition No. 3, 2023
News / Industry / Artificial intelligence: A gift to dentists / Industry / A new endo-resto approach in digital dentistry / Help your patients say yes! / Why is Slow Dentistry calling / Six-month evaluation of a sodium bicarbonate-containing toothpaste for the reduction of established gingivitis: A randomised USA-based clinical trial / “Roxolid is one of the most significant advances in the last 20 years” / News /
- News 1 - 2
- Industry 4 - 4
- Artificial intelligence: A gift to dentists 6 - 6
- Industry 8 - 10
- A new endo-resto approach in digital dentistry 12 - 16
- Help your patients say yes! 20 - 20
- Why is Slow Dentistry calling 22 - 22
- Six-month evaluation of a sodium bicarbonate-containing toothpaste for the reduction of established gingivitis: A randomised USA-based clinical trial 24 - 24
- “Roxolid is one of the most significant advances in the last 20 years” 26 - 28
- News 30 - 30
:sharpen(level=0):output(format=webp)/up/dt/e-papers/350231/1.jpg "DT Turkey No. 4, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/347784/1.jpg "DT Turkey No. 3, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/342388/1.jpg "DT Turkey No. 2, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/338358/1.jpg "DT Turkey No. 1, 2024")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/334259/1.jpg "DT Turkey No. 4, 2023")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/354655/1.jpg "DT Turkey No. 1, 2025")
:sharpen(level=0):output(format=webp)/up/dt/e-papers/354655/2.jpg "ISSUE")